Trials / Unknown
UnknownNCT02356445
Use of Immunosuppressive Therapy for Sarcoidosis
Outcome of Use of Cytotoxic Drugs for Inflammatory Lung Diseases
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- University of Cincinnati · Academic / Other
- Sex
- All
- Age
- 15 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Retrospective review of the outcome of use of immunosuppressive drugs in treatment of sarcoidosis
Detailed description
Patients receiving one or more cytotoxic or other immunosuppressive drug will be observed
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cytotoxic drug | Observe patients versus treatment type |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2018-11-01
- Completion
- 2018-12-01
- First posted
- 2015-02-05
- Last updated
- 2017-08-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02356445. Inclusion in this directory is not an endorsement.